428 related articles for article (PubMed ID: 16464504)
21. Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells.
Hamed HA; Das SK; Sokhi UK; Park MA; Cruickshanks N; Archer K; Ogretmen B; Grant S; Sarkar D; Fisher PB; Dent P
Cancer Biol Ther; 2013 Nov; 14(11):1039-49. PubMed ID: 24025359
[TBL] [Abstract][Full Text] [Related]
22. Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction.
Dash R; Bhoopathi P; Das SK; Sarkar S; Emdad L; Dasgupta S; Sarkar D; Fisher PB
Cancer Res; 2014 Jan; 74(2):563-74. PubMed ID: 24282278
[TBL] [Abstract][Full Text] [Related]
23. mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.
Dash R; Bhutia SK; Azab B; Su ZZ; Quinn BA; Kegelmen TP; Das SK; Kim K; Lee SG; Park MA; Yacoub A; Rahmani M; Emdad L; Dmitriev IP; Wang XY; Sarkar D; Grant S; Dent P; Curiel DT; Fisher PB
Cytokine Growth Factor Rev; 2010 Oct; 21(5):381-91. PubMed ID: 20926331
[TBL] [Abstract][Full Text] [Related]
24. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene.
Kang DC; Gopalkrishnan RV; Lin L; Randolph A; Valerie K; Pestka S; Fisher PB
Oncogene; 2004 Mar; 23(9):1789-800. PubMed ID: 14676839
[TBL] [Abstract][Full Text] [Related]
25. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine.
Sauane M; Gopalkrishnan RV; Sarkar D; Su ZZ; Lebedeva IV; Dent P; Pestka S; Fisher PB
Cytokine Growth Factor Rev; 2003 Feb; 14(1):35-51. PubMed ID: 12485618
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.
Lebedeva IV; Sarkar D; Su ZZ; Kitada S; Dent P; Stein CA; Reed JC; Fisher PB
Oncogene; 2003 Nov; 22(54):8758-73. PubMed ID: 14647471
[TBL] [Abstract][Full Text] [Related]
27. Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.
Menezes ME; Bhoopathi P; Pradhan AK; Emdad L; Das SK; Guo C; Wang XY; Sarkar D; Fisher PB
Adv Cancer Res; 2018; 138():143-182. PubMed ID: 29551126
[TBL] [Abstract][Full Text] [Related]
28. Targeted combinatorial therapy of non-small cell lung carcinoma using a GST-fusion protein of full-length or truncated MDA-7/IL-24 with Tarceva.
Gupta P; Emdad L; Lebedeva IV; Sarkar D; Dent P; Curiel DT; Settleman J; Fisher PB
J Cell Physiol; 2008 Jun; 215(3):827-36. PubMed ID: 18270968
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis.
Lebedeva IV; Su ZZ; Vozhilla N; Chatman L; Sarkar D; Dent P; Athar M; Fisher PB
Mol Cancer Ther; 2008 Jul; 7(7):2042-50. PubMed ID: 18645014
[TBL] [Abstract][Full Text] [Related]
30. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.
Su Z; Lebedeva IV; Gopalkrishnan RV; Goldstein NI; Stein CA; Reed JC; Dent P; Fisher PB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10332-7. PubMed ID: 11526239
[TBL] [Abstract][Full Text] [Related]
31. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
Chada S; Bocangel D; Ramesh R; Grimm EA; Mumm JB; Mhashilkar AM; Zheng M
Mol Ther; 2005 May; 11(5):724-33. PubMed ID: 15851011
[TBL] [Abstract][Full Text] [Related]
32. Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways.
Sauane M; Lebedeva IV; Su ZZ; Choo HT; Randolph A; Valerie K; Dent P; Gopalkrishnan RV; Fisher PB
Cancer Res; 2004 May; 64(9):2988-93. PubMed ID: 15126330
[TBL] [Abstract][Full Text] [Related]
33. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
34. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis.
Gupta P; Walter MR; Su ZZ; Lebedeva IV; Emdad L; Randolph A; Valerie K; Sarkar D; Fisher PB
Cancer Res; 2006 Aug; 66(16):8182-91. PubMed ID: 16912197
[TBL] [Abstract][Full Text] [Related]
35. MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.
Dent P; Yacoub A; Hamed HA; Park MA; Dash R; Bhutia SK; Sarkar D; Gupta P; Emdad L; Lebedeva IV; Sauane M; Su ZZ; Rahmani M; Broaddus WC; Young HF; Lesniak M; Grant S; Curiel DT; Fisher PB
Anticancer Drugs; 2010 Sep; 21(8):725-31. PubMed ID: 20613485
[TBL] [Abstract][Full Text] [Related]
36. Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy.
Emdad L; Lebedeva IV; Su ZZ; Gupta P; Sarkar D; Settleman J; Fisher PB
J Cell Physiol; 2007 Feb; 210(2):549-59. PubMed ID: 17111370
[TBL] [Abstract][Full Text] [Related]
37. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways.
Sauane M; Gopalkrishnan RV; Lebedeva I; Mei MX; Sarkar D; Su ZZ; Kang DC; Dent P; Pestka S; Fisher PB
J Cell Physiol; 2003 Aug; 196(2):334-45. PubMed ID: 12811827
[TBL] [Abstract][Full Text] [Related]
38. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?
Sarkar D; Lebedeva IV; Gupta P; Emdad L; Sauane M; Dent P; Curiel DT; Fisher PB
Expert Opin Biol Ther; 2007 May; 7(5):577-86. PubMed ID: 17477796
[TBL] [Abstract][Full Text] [Related]
39. MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
Chada S; Sutton RB; Ekmekcioglu S; Ellerhorst J; Mumm JB; Leitner WW; Yang HY; Sahin AA; Hunt KK; Fuson KL; Poìndexter N; Roth JA; Ramesh R; Grimm EA; Mhashilkar AM
Int Immunopharmacol; 2004 May; 4(5):649-67. PubMed ID: 15120650
[TBL] [Abstract][Full Text] [Related]
40. Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells.
Zhang BF; Liu JJ; Pei DS; Yang ZX; Di JH; Chen FF; Li HZ; Xu W; Wu YP; Zheng JN
Cancer Biother Radiopharm; 2011 Oct; 26(5):647-55. PubMed ID: 21902545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
